A phase II/III randomized study in advanced non-small-cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel:: second interim study results

被引：0
|
作者：
Müller, A
Thatcher, N
Kortsik, C
Koschel, G
Spengler, W
Pitz, LR
Mezger, J
Manegold, C
机构：
[1] Thoraxklin Heidelberg, Heidelberg, Germany
[2] Christie Hosp, Manchester, Lancs, England
[3] KH Sankt Hildegardis, Mainz, Germany
[4] AKH Hamburg, Hamburg, Germany
[5] KH Schillerhohe, Gerlingen, Germany
[6] German Canc Res Ctr, DKFZ, D-6900 Heidelberg, Germany
[7] St Vincentius Kliniken, Karlsruhe, Germany
来源：
LUNG CANCER | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [1] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel: second interim study results
    Mueller, Annette
    Thatcher, Nick
    Kortsik, Cornelius
    Koschel, Gabriele
    Spengler, Werner
    Pitz, Lothar R.
    Mezger, Joerg
    Manegold, Christian
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 168 - 169
  • [2] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results.
    Mueller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pilz, L
    Mezger, J
    Manegold, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 640S - 640S
  • [3] Sequential versus concomitant administration of docetaxel and gemcitabine as first-line treatment of advanced non-small cell lung cancer (NSCLC):: results of a phase II/III randomised study
    Manegold, C.
    Thatcher, N.
    Kortsik, C.
    Koschel, G.
    Spengler, W.
    Mezgar, J.
    Schott von Romer, K.
    Pilz, L.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 326 - 326
  • [4] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic non-small-cell lung cancer: A multicenter phase II study
    Costa, A
    Almodovar, T
    Seada, J
    Barata, F
    Teixeira, E
    Queiroga, H
    Pires, S
    [J]. PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 117 - 120
  • [5] Randomized multicenter phase II study of gemcitabine versus docetaxel as first-line therapy with second-line crossover in advanced-stage non-small-cell lung cancer
    Manegold, Christian
    Pilz, Lothar Richard
    Koschel, Gabriele
    Roemer, Katrin Schott-von
    Mezger, Joerg
    Hruska, Dagmar
    Dornof, Wolfgang
    Gosse, Helga
    Gatzemeier, Ulrich
    [J]. CLINICAL LUNG CANCER, 2005, 7 (03) : 208 - 214
  • [6] First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study
    Tibaldi, C.
    Vasile, E.
    Lo Dico, M.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    Falcone, A.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 176 - 176
  • [7] Docetaxel-gemcitabine versus cisplatin-gemcitabine plus sequential docetaxel in the first-line treatment of metastatic non-small cell lung cancer (NSCLC): interim results of a randomized Phase II trial
    Binder, Daniel
    Beinert, Thomas
    Schweisfurth, Hans
    Grah, Christian
    Temmestfeld-Wollbrueck, Bettina
    Schaeper, Christoph
    Mueller-Hagen, Gerit
    Schuermann, Dirk
    Suttorp, Norbert
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [8] Concomitant versus sequential gemcitabine (G) and docetaxel (D) as first-line chemotherapy in advanced non-small-cell lung cancer (NSCLC):: updated outcomes and quality of life (QoL) results of a Phase II/III randomised study
    Thatcher, N
    Manegold, C
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Pilz, LR
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 306 - 306
  • [9] Gemcitabine and docetaxel as concomitant or sequential first-line therapy of advanced non-small cell lung cancer:: Updated results of a randomized study
    Manegold, C
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Piiz, L
    [J]. LUNG CANCER, 2005, 49 : S36 - S36
  • [10] First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study
    Lo Dico, M.
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Di Marsico, R.
    Tartarelli, G.
    Fabbri, A.
    Mazzoni, E.
    Andreuccetti, M.
    D'Alessandro, M.
    Nacci, A.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 35 - 35
12345